3 hours ORAMED PHARMACEUTICALS INC. Refinances with New Securities Purchase Agreement MarketBeat
On October 8, 2024, Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) entered into a Securities Purchase Agreement with institutional investors and Scilex, a transaction aimed at refinancing a portion of existing debt and satisfying certain obligations. The ag…